We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Becton Dickinson (BD) Aug. 14 said it was making a $350 million bid for TriPathImaging, a maker of diagnostic tests based Burlington, N.C., in what is seen as a good move.
The Centers for Medicare & Medicaid Services (CMS) announced Aug. 15 it has published new quality standards for suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS).
The FDA is seeking comments on how a unique identification system for devices might reduce medical errors, facilitate recalls and improve adverse event reporting.
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced immediate availability in Africa of the BD Vacutainer CD4 Stabilization Blood Collection Tube.
Syprosoft, Inc. announced that Source Scientific, LLC has retained it to develop image processing software to be used in an eye surgery product that Source Scientific is developing.
BioSphere Medical, Inc., a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced that the U.S. Food and Drug Administration has cleared for marketing in the United States BioSphere Medical's EmboCath Plus Infusion Microcatheter.
Celsion announced Aug. 11 that the FDA had approved its premarket approval supplement for its Prolieve thermodilatation disposable catheter system to treat prostate cancer, after a recall led the agency to request changes in the firm's manufacturing and inspection processes for the device.